Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept intravitreal injection vs laser photocoagulation in diabetic macular edema
CTR20131312Phase 3Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Apr 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of conbercept in diabetic macular edema (DME), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
conbercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on CTR20131312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131312.